GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (STU:72X) » Definitions » Gross Profit

MicroPort CardioFlow Medtech (STU:72X) Gross Profit : €34.81 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MicroPort CardioFlow Medtech Gross Profit?

MicroPort CardioFlow Medtech's gross profit for the six months ended in Jun. 2024 was €20.26 Mil. MicroPort CardioFlow Medtech's gross profit for the trailing twelve months (TTM) ended in Jun. 2024 was €34.81 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. MicroPort CardioFlow Medtech's gross profit for the six months ended in Jun. 2024 was €20.26 Mil. MicroPort CardioFlow Medtech's Revenue for the six months ended in Jun. 2024 was €28.57 Mil. Therefore, MicroPort CardioFlow Medtech's Gross Margin % for the quarter that ended in Jun. 2024 was 70.91%.

MicroPort CardioFlow Medtech had a gross margin of 70.91% for the quarter that ended in Jun. 2024 => Durable competitive advantage

During the past 6 years, the highest Gross Margin % of MicroPort CardioFlow Medtech was 70.91%. The lowest was 29.31%. And the median was 59.11%.


MicroPort CardioFlow Medtech Gross Profit Historical Data

The historical data trend for MicroPort CardioFlow Medtech's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech Gross Profit Chart

MicroPort CardioFlow Medtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial 0.81 5.70 16.49 21.95 29.53

MicroPort CardioFlow Medtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 11.23 11.20 15.03 14.55 20.26

Competitive Comparison of MicroPort CardioFlow Medtech's Gross Profit

For the Medical Devices subindustry, MicroPort CardioFlow Medtech's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroPort CardioFlow Medtech's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's Gross Profit distribution charts can be found below:

* The bar in red indicates where MicroPort CardioFlow Medtech's Gross Profit falls into.



MicroPort CardioFlow Medtech Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

MicroPort CardioFlow Medtech's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=43.179 - 13.649
=29.53

MicroPort CardioFlow Medtech's Gross Profit for the quarter that ended in Jun. 2024 is calculated as

Gross Profit (Q: Jun. 2024 )=Revenue - Cost of Goods Sold
=28.574 - 8.313
=20.26

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €34.81 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

MicroPort CardioFlow Medtech's Gross Margin % for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=20.26 / 28.574
=70.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


MicroPort CardioFlow Medtech  (STU:72X) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

MicroPort CardioFlow Medtech had a gross margin of 70.91% for the quarter that ended in Jun. 2024 => Durable competitive advantage


MicroPort CardioFlow Medtech Gross Profit Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort CardioFlow Medtech Business Description

Traded in Other Exchanges
Address
No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.

MicroPort CardioFlow Medtech Headlines

No Headlines